Literature DB >> 2819733

Topoisomerase II as a target of anticancer drug action in mammalian cells.

K W Kohn, Y Pommier, D Kerrigan, J Markovits, J M Covey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2819733

Source DB:  PubMed          Journal:  NCI Monogr        ISSN： 0893-2751


× No keyword cloud information.
  6 in total

1.  Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.

Authors:  P Fossé; B René; M Le Bret; C Paoletti; J M Saucier
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

2.  Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiation.

Authors:  F Gieseler; F Boege; M Clark
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

3.  Altered expression pattern of topoisomerase IIalpha in ovarian tumor epithelial and stromal cells after platinum-based chemotherapy.

Authors:  Radoslav Chekerov; Irina Klaman; Menelaos Zafrakas; Dominique Könsgen; Alexander Mustea; Beate Petschke; Werner Lichtenegger; Jalid Sehouli; Edgar Dahl
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

4.  Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice.

Authors:  M C Bissery; C H Nguyen; E Bisagni; P Vrignaud; F Lavelle
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

Review 5.  Nucleoside salvage and resistance to antimetabolite anticancer agents.

Authors:  M Fox; J M Boyle; A R Kinsella
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

6.  bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy.

Authors:  S Kondo; D Yin; J Takeuchi; T Morimura; Y Oda; H Kikuchi
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.